Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Abbott India Limited
ABBOTINDIAAbbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited. Address: Godrej BKC, Plot C-68, Mumbai, India, 400051
Analytics
WallStreetin tavoitehinta
2 439 743.98 INRP/E-suhde
48.78Osinkotuotto
1.38 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut ABBOTINDIA
Osinkoanalytiikka ABBOTINDIA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–Osinkojen kasvu 5 vuoden aikana
531.00 %Jatkuva kasvu
2 vuottaMaksusuhde 5 vuoden keskiarvo
55.00 %Osinkohistoria ABBOTINDIA
Osakkeen arvostus ABBOTINDIA
Talousasiat ABBOTINDIA
Tuloksia | 2019 | Dynamiikka |